A structurally engineered fatty acid, icosabutate, suppresses liver inflammation and fibrosis in NASH
David A. Fraser, Xiaoyu Wang, Jenny Lund, Nataša Nikolić, Marta Iruarrizaga‐Lejarreta, Tore Skjæret, Cristina Alonso, John J.P. Kastelein, Arild C. Rustan, Yong Ook Kim, Detlef Schuppan
Topics & Concepts
SteatohepatitisFibrosisInternal medicineFatty liverEndocrinologyInflammationGlutathioneChemistryEicosapentaenoic acidPolyunsaturated fatty acidPharmacologyBiologyBiochemistryMedicineFatty acidEnzymeDiseaseLiver Disease Diagnosis and TreatmentFatty Acid Research and HealthLiver Disease and Transplantation